FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094657539> ?p ?o ?g. }

• W2094657539 endingPage "333" @default.
• W2094657539 startingPage "325" @default.
• W2094657539 abstract "Nevirapine and cotrimoxazole are associated with hematologic toxicities and skin-rash. Safety of their concurrent use for prophylaxis over extended periods among HIV-exposed uninfected infants has not been previously assessed.Secondary data analysis of the 'HIV Prevention Trials Network-046 protocol' (version 2.0), a phase-III, randomized, placebo-controlled trial that assessed efficacy and safety of nevirapine prophylaxis against breast milk transmission of HIV-1.Trial infants received 6-month study nevirapine/placebo, and standard-of-care peripartum single-dose nevirapine+/- zidovudine 'tail', and cotrimoxazole prophylaxis from 6 weeks through breastfeeding cessation. Adverse events were monitored using United States Division of AIDS Toxicity Tables (2004). Risk of neutropenia, anemia and skin-rash in the cotrimoxazole + nevirapine and the cotrimoxazole + placebo groups were compared using negative-binomial regression.Incidence of neutropenia and/or anemia, and skin-rash was highest during the first 6 weeks of life and declined, thereafter, regardless of study group. Time to first adverse event after 6 weeks was similar in cotrimoxazole + nevirapine and cotrimoxazole + placebo groups: hazard ratio (95% confidence interval) was 1.26 (0.96-1.66) for neutropenia and/or anemia (all grades), 1.27 (0.80-2.03) for neutropenia and/or anemia (grade ≥3) and 1.16 (0.46-2.90) for skin-rash (grade ≥2). There were no statistically significant differences in immediate (6 weeks-6 months) and long-term (6-12 months) adverse event risk among infants on cotrimoxazole + nevirapine versus cotrimoxazole + placebo.Extended nevirapine and cotrimoxazole prophylaxis through 6 months of age among HIV-exposed uninfected infants did not appear to increase the immediate or long-term risk of neutropenia, anemia or skin-rash. Concurrent use beyond 6 months, however, needs to be evaluated." @default.
• W2094657539 created "2016-06-24" @default.
• W2094657539 creator A5016065942 @default.
• W2094657539 creator A5037677450 @default.
• W2094657539 creator A5039731482 @default.
• W2094657539 creator A5053714539 @default.
• W2094657539 creator A5057946567 @default.
• W2094657539 creator A5072857823 @default.
• W2094657539 creator A5073211200 @default.
• W2094657539 creator A5076484464 @default.
• W2094657539 creator A5081396402 @default.
• W2094657539 creator A5091507463 @default.
• W2094657539 date "2012-01-28" @default.
• W2094657539 modified "2023-09-30" @default.
• W2094657539 title "Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated" @default.
• W2094657539 cites W1967503024 @default.
• W2094657539 cites W1982971134 @default.
• W2094657539 cites W1997469483 @default.
• W2094657539 cites W2006901216 @default.
• W2094657539 cites W2024884240 @default.
• W2094657539 cites W2036597966 @default.
• W2094657539 cites W2038183880 @default.
• W2094657539 cites W2053865961 @default.
• W2094657539 cites W2060502594 @default.
• W2094657539 cites W2065855820 @default.
• W2094657539 cites W2078913113 @default.
• W2094657539 cites W2089742146 @default.
• W2094657539 cites W2102155948 @default.
• W2094657539 cites W2117950107 @default.
• W2094657539 cites W2126184004 @default.
• W2094657539 cites W2135662203 @default.
• W2094657539 cites W2136127101 @default.
• W2094657539 cites W2150248811 @default.
• W2094657539 cites W2159324987 @default.
• W2094657539 cites W2159944585 @default.
• W2094657539 cites W2162881343 @default.
• W2094657539 cites W2170947401 @default.
• W2094657539 doi "https://doi.org/10.1097/qad.0b013e32834e892c" @default.
• W2094657539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3356697" @default.
• W2094657539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22112598" @default.
• W2094657539 hasPublicationYear "2012" @default.
• W2094657539 type Work @default.
• W2094657539 sameAs 2094657539 @default.
• W2094657539 citedByCount "12" @default.
• W2094657539 countsByYear W20946575392013 @default.
• W2094657539 countsByYear W20946575392014 @default.
• W2094657539 countsByYear W20946575392015 @default.
• W2094657539 countsByYear W20946575392016 @default.
• W2094657539 countsByYear W20946575392017 @default.
• W2094657539 countsByYear W20946575392020 @default.
• W2094657539 countsByYear W20946575392021 @default.
• W2094657539 crossrefType "journal-article" @default.
• W2094657539 hasAuthorship W2094657539A5016065942 @default.
• W2094657539 hasAuthorship W2094657539A5037677450 @default.
• W2094657539 hasAuthorship W2094657539A5039731482 @default.
• W2094657539 hasAuthorship W2094657539A5053714539 @default.
• W2094657539 hasAuthorship W2094657539A5057946567 @default.
• W2094657539 hasAuthorship W2094657539A5072857823 @default.
• W2094657539 hasAuthorship W2094657539A5073211200 @default.
• W2094657539 hasAuthorship W2094657539A5076484464 @default.
• W2094657539 hasAuthorship W2094657539A5081396402 @default.
• W2094657539 hasAuthorship W2094657539A5091507463 @default.
• W2094657539 hasBestOaLocation W20946575391 @default.
• W2094657539 hasConcept C126322002 @default.
• W2094657539 hasConcept C141071460 @default.
• W2094657539 hasConcept C142462285 @default.
• W2094657539 hasConcept C142724271 @default.
• W2094657539 hasConcept C187212893 @default.
• W2094657539 hasConcept C197934379 @default.
• W2094657539 hasConcept C203014093 @default.
• W2094657539 hasConcept C204787440 @default.
• W2094657539 hasConcept C27081682 @default.
• W2094657539 hasConcept C2776694085 @default.
• W2094657539 hasConcept C2777063308 @default.
• W2094657539 hasConcept C2778248108 @default.
• W2094657539 hasConcept C2778570526 @default.
• W2094657539 hasConcept C2779130552 @default.
• W2094657539 hasConcept C2780216070 @default.
• W2094657539 hasConcept C2780727368 @default.
• W2094657539 hasConcept C2993143319 @default.
• W2094657539 hasConcept C3013748606 @default.
• W2094657539 hasConcept C71924100 @default.
• W2094657539 hasConceptScore W2094657539C126322002 @default.
• W2094657539 hasConceptScore W2094657539C141071460 @default.
• W2094657539 hasConceptScore W2094657539C142462285 @default.
• W2094657539 hasConceptScore W2094657539C142724271 @default.
• W2094657539 hasConceptScore W2094657539C187212893 @default.
• W2094657539 hasConceptScore W2094657539C197934379 @default.
• W2094657539 hasConceptScore W2094657539C203014093 @default.
• W2094657539 hasConceptScore W2094657539C204787440 @default.
• W2094657539 hasConceptScore W2094657539C27081682 @default.
• W2094657539 hasConceptScore W2094657539C2776694085 @default.
• W2094657539 hasConceptScore W2094657539C2777063308 @default.
• W2094657539 hasConceptScore W2094657539C2778248108 @default.
• W2094657539 hasConceptScore W2094657539C2778570526 @default.
• W2094657539 hasConceptScore W2094657539C2779130552 @default.
• W2094657539 hasConceptScore W2094657539C2780216070 @default.
• W2094657539 hasConceptScore W2094657539C2780727368 @default.

• next